Lombard Medical Statistics
Total Valuation
Lombard Medical has a market cap or net worth of 28.
| Market Cap | 28 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Lombard Medical has 27.95 million shares outstanding.
| Current Share Class | 27.95M |
| Shares Outstanding | 27.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +4.54% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.33, with a Debt / Equity ratio of 2.47.
| Current Ratio | 3.33 |
| Quick Ratio | 2.60 |
| Debt / Equity | 2.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.36 |
| Interest Coverage | -10.85 |
Financial Efficiency
Return on equity (ROE) is -108.73% and return on invested capital (ROIC) is -27.80%.
| Return on Equity (ROE) | -108.73% |
| Return on Assets (ROA) | -20.78% |
| Return on Invested Capital (ROIC) | -27.80% |
| Return on Capital Employed (ROCE) | -44.23% |
| Revenue Per Employee | 107,690 |
| Profits Per Employee | -274,646 |
| Employee Count | 113 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 1.65 |
Taxes
| Income Tax | -1.48M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 1.94 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.25 |
Income Statement
In the last 12 months, Lombard Medical had revenue of 12.17 million and -31.04 million in losses. Loss per share was -1.54.
| Revenue | 12.17M |
| Gross Profit | 1.14M |
| Operating Income | -25.52M |
| Pretax Income | -32.52M |
| Net Income | -31.04M |
| EBITDA | -24.22M |
| EBIT | -25.52M |
| Loss Per Share | -1.54 |
Balance Sheet
The company has 20.80 million in cash and 34.56 million in debt, giving a net cash position of -13.76 million or -0.49 per share.
| Cash & Cash Equivalents | 20.80M |
| Total Debt | 34.56M |
| Net Cash | -13.76M |
| Net Cash Per Share | -0.49 |
| Equity (Book Value) | 13.97M |
| Book Value Per Share | 0.50 |
| Working Capital | 23.51M |
Cash Flow
In the last 12 months, operating cash flow was -25.20 million and capital expenditures -265,000, giving a free cash flow of -25.46 million.
| Operating Cash Flow | -25.20M |
| Capital Expenditures | -265,000 |
| Free Cash Flow | -25.46M |
| FCF Per Share | -0.91 |
Margins
Gross margin is 9.38%, with operating and profit margins of -209.72% and -255.03%.
| Gross Margin | 9.38% |
| Operating Margin | -209.72% |
| Pretax Margin | -267.20% |
| Profit Margin | -255.03% |
| EBITDA Margin | -199.03% |
| EBIT Margin | -209.72% |
| FCF Margin | n/a |
Dividends & Yields
Lombard Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.60% |
| Shareholder Yield | n/a |
| Earnings Yield | -110,839,285.71% |
| FCF Yield | -90,928,571.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Lombard Medical has an Altman Z-Score of -5.74 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.74 |
| Piotroski F-Score | 1 |